Karrie Wheatley, Ph.D., represents clients in patent cases in U.S. District Courts throughout the country and at the U.S. International Trade Commission, as well as in inter partes review and post-grant review proceedings at the Patent Trial and Appeal Board. 

She also represents branded pharmaceutical companies in Hatch-Waxman litigation. Her practice encompasses all aspects of patent litigation from pre-suit diligence to post-trial briefing, including taking and defending depositions, and working closely with technical witnesses and experts. 

Karrie tackles complex issues across a wide range of industries and is frequently sought out for her insights into technical matters that are unique, uncommon, or raise novel questions of law. She has extensive experience with technologies as varied as graphics processing units, noise suppression technologies, FinFET design, automated oil and gas technology, hydraulic fracturing, biodiesel extraction, novel ophthalmic formulations, CPAP masks for the treatment of sleep apnea, and personalized medicine in cancer treatment. 

With a Ph.D. in nutritional sciences, Karrie’s technical background runs particularly deep. During graduate school and a postdoctoral fellowship at MD Anderson Cancer Center, Karrie performed breast cancer research that was funded by competitive grants from National Cancer Institute. Her primary areas of research involved overexpressed genes for potential drug targets in triple-negative breast cancer and novel regimens to induce synthetic lethality as a cancer therapeutic. Karrie’s extensive research experience gives her unique insights into her clients’ day-to-day operations and informs many of her litigation strategies. 

In addition to her intellectual property practice, Karrie maintains an active pro bono practice, representing clients facing removal proceedings in the Houston Immigration Court.